The Future of Cancer Care

U.S. Representative Mike Kelly has served in Congress since 2011 and proudly represents Pennsylvania’s 16th District. He grew up in Butler, Pennsylvania, and graduated from Butler High School in 1966, after which he attended the University of Notre Dame on a football and academic scholarship. After college, Rep. Kelly moved back to Butler to work at Kelly Chevrolet-Cadillac, Inc., a company founded by his father in the early 1950s. He took over the dealership in the mid-1990s and expanded its operations to include Hyundai and KIA franchises which altogether currently employ more than 100 people from throughout the region. 

Rep. Kelly previously served as a founding board member of the Hyundai “Hope on Wheels” initiative, which to date has donated more than $145 million to childhood cancer research institutions nationwide. He continues to work with the organization as a lawmaker.

The Pittsburgh Tribune-Review refers to Rep. Kelly as “Butler’s straight talker” and “a true man of the people.” According to CQ Roll Call, “Any encounter with Kelly has the potential to erupt into a pep rally” thanks to his “gift for enthusiastic – and rapid-fire – communication.” Breitbart News calls Rep. Kelly "a fierce defender of conservatism on Capitol Hill." Fox News Channel’s Neil Cavuto calls him “a key player” and “a mover and shaker” in the U.S. House of Representatives.

Rep. Kelly currently sits on the House Ways and Means Committee and is the Chairman of the Subcommittee on Tax. 

He and his wife Victoria have four children and are the proud grandparents to ten wonderful grandchildren.

Below are just a few of the awards and distinctions that Mike has received while serving Pennsylvania’s 16th District:

• 60 Plus Association: Guardian of Seniors' Rights Award
• American Conservative Union: ACU Conservative Award
• American Farm Bureau Federation: Friend of Farm Bureau Award
• American International Automobile Dealers: Legislative Action Network Advocacy Award
• Association of Mature American Citizens: Friend of AMAC Award
• Family Research Council Action: True Blue Award
• Hyundai Hope on Wheels: Ambassador of Hope Award
• International Foodservice Distributers Association: Jefferson Award
• National Association of Manufacturers: Award for Manufacturing Legislative Excellence
• National Federation of Independent Business: Guardian of Small Business Award
• National Retail Federation: Hero of Main Street Award
• U.S. Chamber of Commerce: Spirit of Enterprise Award

Juan Pablo Uribe is the Global Director for Health, Nutrition and Population at the World Bank and Director of the Global Financing Facility for Women, Children and Adolescents (GFF). Previously, from 2018 to 2019, Dr. Uribe served as Minister of Health and Social Protection of Colombia. Between 2009 and 2011, he was the World Bank´s Health Sector Manager for East Asia and the Pacific. In his vast career, first as a medical doctor specialized in public health and public administration, and later in both public and private leading health sector organizations, Mr. Uribe has contributed significantly to public health policies, health care delivery and health systems development.  

Dr. Mayesha Alam is vice president of research at FP Analytics where she oversees the research team and leads research development for clients and partners. She previously helped establish and served as deputy director of the Georgetown Institute for Women, Peace and Security, and has also worked with the United Nations, World Bank, Organization for Security and Co-operation in Europe, and various nongovernmental organizations. Dr. Alam is the author of two books, Women and Transitional Justice and, with Robert Egnell, Women and Gender Perspectives in the Military, as well as reports on conflict, climate change, health, and gender. Her commentary has appeared in the Washington Post, CNN, NPR, Newsweek, and elsewhere. A nonresident senior fellow of the United Nations University Centre for Policy Research, Dr. Alam is a professor at Johns Hopkins SAIS, and holds a Ph.D. from Yale University.

Originally from South Africa, Dr. Catharine Young holds a doctorate degree in Biomedical Sciences and completed her Postdoctrate training in Biomedical Engineering. Currently she serves at the White House Office of Science and Technology Policy to advance the Cancer Moonshot - The President and First Lady’s mission to decrease the number of cancer deaths by 50% over the next 25 years. Besides Catharine’s federal government experience, Catharine’s career has spanned a variety of sectors including academia, non-profit, biotech, and foreign government, all with a focus on advancing science. Awards include being selected as a TED Fellow, a New Voices Fellow of the National Academies of Science, Engineering and Medicine, a Presidential Leadership Scholar, and Social Enablers top 100 most inspiring social entrepreneurs. Catharine is an advocate for women in STEM and has been a contributor to major social and media networks including TED-Ed, the Guardian and the UK Science and Innovation Network.

Dr. Danielle Bitterman is a physician-scientist in the Artificial Intelligence in Medicine Program at Mass General Brigham and the Department of Radiation Oncology at Brigham and Women’s Hospital/Dana-Farber Cancer Institute. She is an Assistant Professor of Radiation Oncology at Harvard Medical School. Her research is dedicated to translating advances in artificial intelligence to the cancer clinic. Her laboratory develops and clinically validates natural language processing technologies that converts information in electronic health records into intelligent systems that actively support patients, caregivers, and clinicians by facilitating communication, education, and data-driven insights. Dr. Bitterman received her undergraduate degree at Columbia University and attended medical school at New York University School of Medicine. She completed an internship in internal medicine at the Brigham and Women's Hospital, and her residency at the Harvard Radiation Oncology Program. She completed her post-doctoral fellowship in natural language processing at the Computational Health Informatics Program at Boston Children’s Hospital.

Allison Carlson is the Executive Vice President of FP Analytics & Events at Foreign Policy. She oversees FPA’s cross-cutting research at the intersection of policy, technology, and global markets as well as Foreign Policy’s global dialogues and convenings. Prior to these roles, Carlson led FP Analytics’ energy and technology team for more than a decade, evaluating evolving climate and emissions policies and identifying opportunities for advanced technology deployment internationally. Before joining FP, she led the Latin America program for a boutique consulting firm assisting European companies on investing in emerging markets’ energy and financial sectors. Carlson has presented her work at a variety of international conferences and before the U.S. Senate. She is a graduate of the Johns Hopkins University School of Advanced International Studies, where she received a master’s degree in international relations and international economics.

L. Felice Gorordo is the World Bank Group Alternate Executive Director for the United States since September 2023. Mr. Gorordo brings two decades of leadership experience in management and governance, serving as CEO of three venture-backed technology companies, investor and advisor at two venture capital funds with global mandates in healthcare and infrastructure, and board member on several for-profit and non-profit boards.

Most recently, Mr. Gorordo was CEO of eMerge Americas and Executive Director of the Technology Foundation of the Americas, which focuses on fostering innovation and entrepreneurship across the Americas. He also served as a venture partner at I Squared Capital, a global infrastructure platform managing assets with over $40 billion in Enterprise Value. Additionally, Mr. Gorordo co-founded and led Roots of Hope, (Raíces de Esperanza), a non-profit focused on youth empowerment in Cuba through technology and entrepreneurship.

Previously, Mr. Gorordo was President & CEO of Clearpath, a venture-backed tech company focused on empowering immigrants and revolutionizing the U.S. immigration filing process. Felice also served as advisor to the Biden Cancer Initiative, and Global Director at the venture capital fund StartUp Health.

Prior to that, Mr. Gorordo was appointed by President Barack Obama as one of fifteen White House Fellows and served in the White House Office of Public Engagement & Intergovernmental Affairs. In President George W. Bush’s Administration, Mr. Gorordo served in various positions at the U.S. Departments of Commerce, State, and Homeland Security.

Mr. Gorordo has appeared as a guest commentator on CNN, CNN en Español, BBC, NPR, CNBC, Bloomberg, NBC Nightly News, Univision, and Telemundo. His views and articles have also been published in Forbes, Fortune, Fast Company, The Economist, The Washington Post, The New York Times, The Wall Street Journal, The Miami Herald and el Nuevo Herald.

Felice Gorordo received a Bachelor of Arts from Georgetown University and served as a Senior Fellow at the Georgetown Beeck Center for Social Impact & Innovation. He is a Lifetime Member of the Council on Foreign Relations, and resides in Miami, FL, with his wife Bianca and three children.

Dr. Gralow is the Chief Medical Officer (CMO) and Executive Vice President of ASCO, and brings to her role deep expertise in patient care, research, education, and global health.

Previously, she was the Jill Bennett Endowed Professor of Breast Cancer at the University of Washington School of Medicine, Professor in the Clinical Research division of the Fred Hutchinson Cancer Research Center, as well as Director of Breast Medical Oncology at the Seattle Cancer Care Alliance.

Dr. Gralow is strongly committed to advancing equity in cancer care. As founder of the Women’s Empowerment Cancer Advocacy Network (WE CAN), she supports patient advocates in low- and middle-resource countries. In addition, she served as an adjunct professor in the University of Washington’s Department of Global Health, as a member of the University of Washington’s Breast Cancer Equity Initiative, as Medical Director for Women’s Cancer-related Population Health at the University of Washington, and as an advisory council member for the Uganda Cancer Institute’s adult Hematology/Oncology Fellowship Training Program. Dr. Gralow received the ASCO Humanitarian Award in 2018 for her work in empowering women cancer patients and survivors globally.

She is a recognized leader in breast cancer clinical research, and has conducted clinical trials in breast cancer prevention, treatment, and survivorship. Dr. Gralow served in leadership roles for the SWOG Cancer Research Network funded by the National Cancer Institute (NCI), including as Vice Chair of the Breast Cancer Committee and Executive Officer of Breast and Lung Cancer.

Before joining ASCO full-time, Dr. Gralow served the Society in a variety of volunteer and leadership roles, including chairing the ASCO Academic Global Oncology Task Force, co-chairing the ASCO Resource Stratified Guideline Advisory Group, and serving on the editorial board of the European Society of Medical Oncology (ESMO)/ASCO Global Curriculum in Medical Oncology.

She also has been involved with numerous other nonprofit organizations, including Team Survivor Northwest, an exercise and fitness program for woman cancer survivors which she co-founded in 1995 and serves as Team Physician; a medical advisory committee member for Cierra Sisters African American Support Group; an advisory board member of Global Focus on Cancer; and a Board member of Peace Island Medical Center, a rural access hospital in Washington State.

Dr. Gralow received her bachelor’s degree from Stanford University and her medical degree from the University of Southern California School of Medicine. She trained in internal medicine at Brigham and Women's Hospital at Harvard Medical School and completed a medical oncology fellowship at University of Washington/Fred Hutchinson Cancer Research Center in Seattle.

Dr. Jason Hipp, MD/PhD is the Chief Digital Innovation Officer for Mayo Collaborative Services (the commercial diagnostics arm of Mayo Clinic) and the Medical Director for Biopharma Diagnostics business unit.  He is a MD/PhD board certified pathologist with fellowship training in Informatics.  He has been active in the field of digital pathology for the past 13 years and has spent most of hist time in Industry, having worked at Novartis, BMS and AstraZeneca.  He was also the first pathologist hired by Alphabet and was the lead pathologist at Google.  He spent two years before his current role in Mayo Clinic’s Practice, where he was the founder and Chair of the Division of Computational Pathology & Artificial Intelligence.

Dr. Anshu Jain is the Chief Medical Officer at Aster Insights, a leading oncology bioinformatics company connecting patients and industry through a nationwide research consortium of leading cancer centers.  Dr. Jain is double board certified in radiation oncology and clinical informatics, with longstanding interests in the power of data to advance cancer research and patient care. He is a strong proponent of oncology value-based care, with expertise in various oncology alternative payment models as well as clinical practice leadership in CMS' Oncology Care Model. Dr. Jain has extensive oncology research experience, having published work in journals such as Nature Communications, the Journal of Clinical Oncology, JCO Clinical Cancer Informatics, and the Journal of Oncology Practice.  Dr. Jain has served in several oncology leadership roles focused on improving the quality of cancer care including the ASCO Quality Care Council, ASCO/Niarchos Foundation Advisory Board for cancer care improvement in underserved communities, and serving as a clinical liaison for the NCI SEER program. He previously served as a Senior Fellow in Oncology Innovation at the NCI/FDA focusing on large scale cancer data initiatives.  Dr. Jain received his undergraduate degree from Duke University, and medical degree from the University of Kentucky with highest distinction. He completed an internship in internal medicine from the Massachusetts General Hospital, followed by a residency in radiation oncology at New York Presbyterian Hospital - Columbia University.  He is an Assistant Professor at the Yale School of Medicine, and serves on the boards of the Community Oncology Alliance and the Duke Cancer Institute.

Gary A. Puckrein, PhD, is President and Chief Executive Officer of the National Minority Quality Forum (formerly the National Minority Health Month Foundation), a not-for-profit organization that he founded in 1998. The Forum addresses the critical need for strengthening national and local efforts to use evidence-based, data-driven initiatives to guide programs to eliminate the disproportionate burden of premature death and preventable illness for racial and ethnic minorities and other special populations. The goal of the Forum is to strengthen the capacity of local communities to eliminate the disproportionate burden of premature death and preventable illness in minority populations through prevention, early detection, and control of disease complications. Dr. Puckrein also serves as the Executive Director of the Alliance of Minority Medical Associations (a collaborative effort of the Asian and Pacific Physicians’ Association, the Association of American Indian Physicians, the Interamerican College of Physicians and Surgeons, and the National Medical Association), which was formed on the basis of evidence-based data that highlight significant disparities in health-care treatment plans and outcomes among many underserved populations within the United States. In April 2001, the National Minority Health Month Foundation launched National Minority Health Month in response to Healthy People 2010, the national health-promotion and disease-prevention initiative.

The National Minority Quality Forum has received support from a wide variety of organizations, including federal agencies, pharmaceutical companies, payers, and trade associations. With support from the U.S. Department of Health and Human Services and the Robert Wood Johnson Foundation, the Forum undertook the Zip Code Analysis Project, developing a comprehensive database that links vital statistics and other elements—including demographic, environmental, claims, prescription, laboratory, hospital, and clinic data—in a centralized data warehouse, organized around zip codes. The Zip Code Analysis Project has enabled the Forum to develop the Health Assessment Tool, which measures and forecasts health status in small geographic areas, evaluates the impact of specific interventions, monitors changes in health outcomes, and undertakes risk assessments (health-care utilization and its financial implications). The Forum uses the Health Assessment Tool to stratify communities by geographic and health-status referents and to provide the health-disparities movement with a common set of indicators to measure and report on progress toward the elimination of disparities in health care and health status.

Dr. Puckrein was graduated Phi Beta Kappa from Brown University, where he received his master’s degree (1974) and doctorate (1978). Between 1974 and 1992, he taught and lectured at Roger Williams College, Brown University, Connecticut College, and Rutgers University, where he was a tenured member of the faculty. Dr. Puckrein has received many awards and honors, including being named a visiting scholar and fellow at the Smithsonian’s National Museum of American History and a visiting fellow at Princeton University. He was publisher of American Visions, the country’s leading African American art and cultural magazine, which he launched during his tenure at the Smithsonian Institution and Rutgers University. Dr. Puckrein also created and launched Minority Health Today, which served the needs of clinicians practicing in minority communities.

Manan Shah is Vice President of Global Health Equity & Policy Partnerships at Bristol Myers Squibb. He has over 15 years of US and international health policy, equity, advocacy, public affairs, and communications experience. Prior to BMS, Manan was Head of Global Public Affairs for LEO Pharma. Earlier in his career, Manan was at Biogen and Novo Nordisk in various US, regional and global roles including leading public affairs for emerging markets based in Switzerland. 

He is currently a Lecturer at the Bloustein School of Planning and Public Policy at Rutgers University and served previously as adjunct Assistant Professor of Public Health at Fairleigh Dickinson University’s Schools of Pharmacy & Health Sciences and Public & Global Affairs. He has designed and taught numerous courses including Social Determinants of Health, Politics & Public Health, and Issues in Global Health. Manan also serves on the Dean’s Council of Advisors for the School of International Service at American University and is a Strategic Advisor of the Rutgers Institute for Corporate Social Innovation. He serves on the boards of NYBIO and The Brain Donor Project and is a mentor at Rutgers University’s Road to Industry program.

Manan received his MBA from the University of Illinois-Urbana Champaign, and Master of Public Affairs & Politics from Rutgers University. He also has completed post-graduate studies at the Kennedy School of Government at Harvard University and the Institute of Engineering & Biotechnology at the University of Cambridge. He completed his undergraduate studies at American University. 

Dr. Shamsheer Vayalil is the Chairman of Burjeel Holdings, one of the leading healthcare services providers in the UAE. An entrepreneur and philanthropist, Dr. Shamsheer set up the first hospital, LLH Hospital, in Abu Dhabi in 2007 to address a gap in top-quality tertiary care in the UAE. In the last 15 years, Dr. Shamsheer has tirelessly worked to build one of the largest and most dynamic healthcare companies in the Gulf and the Middle East. Through Dr. Shamsheer’s vision and strategy, Burjeel Holdings swiftly expanded into diverse brands comprising hospitals, medical centers, homecare and occupational health, and retail pharmacies. During the COVID-19 pandemic, Dr. Shamsheer and Burjeel Holdings have been at the forefront of mobilizing advanced healthcare protocols through screening, testing, treating, and vaccinating people across the UAE, Oman, and India. Dr. Shamsheer has received numerous global and local awards for his continuous pursuit of excellence in developing healthcare, philanthropy, and entrepreneurship across the region. He is the recipient of the Pravasi Bharatiya Samman Award, India’s highest civilian award presented to Non-Resident Indians, and is among the first investors to receive a long-term residency in the UAE and Oman. Dr. Shamsheer is a member of the UAE Medical Council. Born in Kozhikode in the south Indian state of Kerala, Dr. Shamsheer pursued MBBS and MD in radiology in India. Growing up in a family environment in his native Kerala, Dr. Shamsheer attributes his inclination for philanthropy to the value system fostered by his parents, where doing charity is an inherent part of the family. He hopes his philanthropic efforts will make a deep impact on public health globally and inspire other young entrepreneurs to follow suit.